It is primarily approved for managing type 2 diabetes but has shown significant weight loss benefits, leading to its off-label use for obesity treatment
HA BRMILYEN SZAKMAI JELLEG KRDSE, KREM, Ginepp cseppek- krds esetn hvjon minket 06-1/211-00-28 A kvetkez lers errl a 2012-ig elrhet injekci hatsairl szl, melyet klinikai ksrletek tmasztanak al, dr Varga Gyula kazincbarcikai gyermekgygysz nevvel fmjelzett gondolatokat tartalmaz
16 Finally, compared to other GLP-1 receptor agonists like dulaglutide, semaglutide is generally more potent, longer-acting, and often leads to greater HbA1c reductions and weight loss
Results are expressed as mean standard deviation (Abbreviations: dB = decibels
Because delayed gastric emptying is part of the mechanism, the interaction between what someone eats and how they feel afterward is real and individual